Testicular and Penile Tumor Center
Testicular cancer is a rare disease but the most common malignant tumor of the young man. The excellent cure rates of this tumor disease are mainly based on compliance with the sometimes complex stadia-adapted treatment guidelines. A close interdisciplinary collaboration between urology, oncology, radio-oncology as well as pathology, radiology and vascular, visceral and thoracic surgery is crucial to achieve the best possible diagnosis, therapy and aftercare. The USZ's Certified Testicular and Penile Tumor Center, with its unique interdisciplinary testicular tumor consultation in Switzerland and the interdisciplinary Tumor Board, provides the platform for optimal care of testicular cancer patients.
In early stages:
- High inguinal ablatio testis with or without frozen section control
- Testicular preserving partial resection
- Testicular biopsies
- Percutaneous irradiation
- Retroperitoneal lymphadenectomy with or without nervousness
- Pain management
Research & trials
The cohort study (Swiss Austrian German Testicular Cancer Cohort Study) provides for the registration of as many as possible testicular cancer patients in Germany, Austria and Switzerland. Here you can find more information about the study
University Hospital Zurich staff who are involved in oncological treatment provide care for oncology patients on an interdisciplinary basis. In
tumor boards, staff hold interdisciplinary discussions and jointly determine the best treatment for patients.
Referring physicians can register in advance and take part in the forums and present their patients to the forum or forward their patient files for evaluation in order to receive a treatment recommendation.
To present patients at a tumor forum, please contact the respective